Clinical tumor response monitoring
tumor
TUMOR, METASTASES
To complete clinical tumor marker detection, sufficient blood samples were collected at multiple time points before and after neoantigen vaccine therapy. Patients were evaluated for measurable tumor metastases with an enhanced CT scan every 2 months.